For the Inventor, By the Inventor

Enter assignee name

Jerusalem, Israel

Gamida Cell Ltd.

USPTO Granted Patents = 20

% Expired Patents = 45.0

CIPO Patents = 1

EPO Patents = 8

Forward Citations = 146

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Tony Peled (20 out of 22 patents)

Avi Treves (10 out of 10 patents)

Eitan Fibach (7 out of 9 patents)

4. Oren Rosen (3 out of 3 patents)

5. Yair Steinhardt (2 out of 2 patents)

6. Arik Hasson (1 out of 3 patents)

7. Gabi M Frei (1 out of 1 patent)

8. Efrat Landau (1 out of 1 patent)

9. Dorit Harati (1 out of 1 patent)

10. David Snyder (1 out of 1 patent)

11. Einat Galamidi Cohen (1 out of 1 patent)

12. Mark M Friedman (0 patent)

20 patents: Sort by Forward Citations

1. 11834677 - Expansion and use of expanded NK cell fractions (2023-12-05),

2. 11746325 - Selection and use of umbilical cord cell fractions suitable for transplantation (2023-09-05),

3. 11730771 - Selection and use of umbilical cord cell fractions suitable for transplantation (2023-08-22),

4. 10047345 - Culturing of mesenchymal stem cells with FGF4 and nicotinamide (2018-08-14),

5. 9567569 - Methods of culturing and expanding mesenchymal stem cells (2017-02-14),

6. 9175266 - Enhancement of natural killer (NK) cell proliferation and activity (2015-11-03),

7. 8986992 - Expansion of stem/progenitor cells by inhibition of enzymatic reactions catalyzed by the Sir2 family of enzymes (2015-03-24),

8. 8846393 - Methods of improving stem cell homing and engraftment (2014-09-30),

9. 8202724 - Methods of controlling proliferation and differentiation of stem and progenitor cells (2012-06-19),

10. 8187876 - Expansion of stem/progenitor cells by inhibition of enzymatic reactions catalyzed by the Sir2 family of enzymes (2012-05-29),

11. 8080417 - Methods of ex vivo hematopoietic stem cell expansion by co-culture with mesenchymal cells (2011-12-20),

12. 7955852 - Expansion of renewable stem cell populations (2011-06-07),

13. 7855075 - Methods of controlling proliferation and differentiation of stem and progenitor cells (2010-12-21),

14. 7655225 - Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby (2010-02-02),

15. 7429489 - Methods of controlling proliferation and differentiation of stem and progenitor cells (2008-09-30),

Gamida Cell is a clinical-stage biotechnology company that specializes in the development of cellular and immune therapies for the treatment of cancer and rare genetic diseases. The company's products are based on its proprietary NAM-based technology platform that enhances the engraftment and therapeutic capabilities of hematopoietic stem cells. Gamida Cell's mission is to harness the power of cell therapy to deliver transformative treatments to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Gamida Cell Ltd.

20 Patents

#12 in Jerusalem

#304 in Israel

#31,176 in the World

Jerusalem, Israel

Gamida Cell Ltd.

Forward Citations = 146

11 inventors:

Tony Peled (20 out of 22 patents)

Avi Treves (10 out of 10 patents)

Eitan Fibach (7 out of 9 patents)

4. Oren Rosen (3 out of 3 patents)

5. Yair Steinhardt (2 out of 2 patents)

Please report any incorrect information to [email protected]

Loading…